TSX News -
Canoe Financial Launches New Defensive Global Balanced Solution With Enhanced Risk Management
CALGARY, Alberta, April 13, 2020 (GLOBE NEWSWIRE) — Canoe Financial LP today announced the launch of Canoe Defensive Global Balanced […]
HEXO Corp. Closes $46 Million Underwritten Public Offering
OTTAWA, April 13, 2020 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the […]
HEXO Corp. clôture un placement public par prise ferme de 46 millions de dollars
OTTAWA, 13 avr. 2020 (GLOBE NEWSWIRE) — HEXO Corp. (« HEXO », ou la « Société ») (TSX : HEXO ; NYSE : HEXO) […]
SCYNEXIS and Aspire Capital Enter into $20 Million Common Stock Purchase Agreement
SCYNEXIS has the ability, at its discretion, to efficiently access up to $20 million of capital$20 million purchase agreement, combined […]
Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update
ATLANTA, April 13, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in […]
Overstock Announces Filing of Prospectus Supplements
SALT LAKE CITY, April 13, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) announces the filing today of a prospectus supplement […]
OSS Initiates $3 Million Reorganization and Expense Reduction Program to Support Long-term Sustainability and Future Growth
ESCONDIDO, Calif., April 13, 2020 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge […]
Ideal Power to Host Business Update Conference Call on Tuesday, April 14, 2020 at 4:30 p.m. Eastern Time
AUSTIN, Texas, April 13, 2020 (GLOBE NEWSWIRE) — Ideal Power Inc. (NASDAQ: IPWR), pioneering the development and commercialization of highly efficient […]
Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board
VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or […]
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Emergency Medical Program in Patients with Septic Shock Due to COVID-19 at CHIREC Delta Hospital, Brussels, Belgium
SAN DIEGO, April 13, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development […]
